tip off
PHARMACEUTICAL BENEFITS SCHEME |

Tony Abbott’s Medicare “deforms” or How to Trick Senators 1.01

The Federal Government’s co-payments Plan B will add another layer of co-payment complexity to the Medicare system that neither doctors nor patients fully understand now. That raises a whole range of issues around unintended consequences, particularly for patients but also for our system, which has prompted this appeal to the Senate to learn from what’s [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Antibiotic Awareness Week: On the path to least resistance

This post below from Professor John Turnidge,  Senior Medical Advisor at the Australian Commission on Safety and Quality in Health Care, marks Antibiotic Awareness Week (Nov 17-23). It outlines how the Commission’s release of the Antimicrobial Stewardship Clinical Care Standard is another significant step along the path to ‘least antibiotic resistance’, but reports also on [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Simulation and scepticism: reflections on road blocks to integrated health care

Croakey recently published this report on an Integrated Care Simulation run by the Australian Healthcare and Hospitals Association (AHHA) in Canberra that invited around 85 health leaders to come together to road test three major potential health policy initiatives: the introduction of bundled care packages for people with chronic diseases a role for private health [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Outsourcing Medicare: Is it as easy as π?

Following on from the range of issues raised by Croakey contributors about the outsourcing of MBS and PBS payments, Margaret Faux discusses the most appropriate role for the private sector in supporting core government functions and the risks involved when private sector interests conflict with the central role of government. She writes: In a U.S [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

And still the evidence and argument mount against a $7 GP co-payment.

The Senate’s Community Affairs References Committee on Friday published its findings on out of pocket costs in Australian healthcare, saying that imposing additional costs would make it harder for people, particularly in vulnerable groups to access primary care, which would not only be at the cost of their own health but to the whole system, [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Unhealthy haste? What are the implications of outsourcing Medicare, PBS claims and services?

Less than two weeks ago the Federal Government called for Expressions of Interest (EOI) from the private sector to provide claims and payment services for Medicare (MBS) and the Pharmaceutical Benefits Scheme (PBS), a $29 billion operation currently managed by the Department of Human Services. The EOI closes this Friday, 22 August. Such a privatisation [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

GP co-payments – deregulation of the bulk billing market.

In this second of a series of posts about Medicare, Margaret Faux  looks at how perverse financial incentives, the increased financial pressure applied to pensioners and GPs and the lack of supporting infrastructure make the Federal Government’s $7 GP co-payment proposal a high risk venture.  See her first post here. *** Margaret Faux writes: The [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

On the risks of private health cover of GP visits & the need for a “real” national conversation on health

In this post below, public policy expert John Menadue agrees with Health Minister Peter Dutton that we need a national conversation about health. He disagrees however that we are having one, saying we are instead seeing an “ill-considered and ideologically driven course” on both co-payments and the prospect of private health insurers being able to [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

#Budget2014 medical research fund is “unfair and unethical”

Prime Minister Tony Abbott declared on ABC Radio National’s Breakfast program this morning: “There are no cuts to health or education. In health, all of the money we are saving is going into the Medical Research Investment Fund and that’s going to be dedicated to finding the treatments and the cures of the future that [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

More strong verdicts on the Audit Commission’s “cruel, unfair, ignorant” proposals on health

This post compiles further reaction to health related recommendations of the National Commission of Audit, whose report to the Federal Government was released yesterday. First up is an impassioned response from Tim Woodruff, vice president of the Doctors Reform Society, on expansion of private health insurance and the proposals to impose a $15 GP co-payment [...]

READ MORE

Womens Agenda

loading...

Smart Company

loading...

StartupSmart

loading...

Property Observer

loading...